Hepatitis Vaccine Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC621

Introduction

Hepatitis vaccine is an antidote for hepatitis disease. Hepatitis B, a life endangering liver infection, is caused by hepatitis B virus, and this vaccine is the solitary highly effective method of preventing this infection in comparison to any other available treatment. As per the World Health Organization (WHO), the prevalence of hepatitis infection is the most across Western Pacific and African region and the least across America.

Market Dynamics

The global hepatitis vaccine market is analyzed to be affected by a number of factors. As indicated over the years by WHO, this disease takes place in infants. The rising number of cases of Hepatitis-B virus is key factor driving the need for this vaccine currently. The appreciable rise in the awareness of hepatitis infection prevention among people coupled with numerous governments across the globe rolling out hepatitis immunization and vaccination policies within their national immunization schedules are the factors analyzed to boost the market growth for hepatitis vaccine, globally. Due to the availability of fewer antibiotics, only this vaccine immunes from the disease. Also, it's medical treatment and medicines are highly expensive. These are the major factors analyzed to hinder the growth of hepatitis vaccine market worldwide.

Market Classification

The global hepatitis vaccine market is classified by products into Hepatitis B vaccine, Anti-Viral Drugs, Lamivudine, Famciclovir, Acyclovir, Fascornet, Adefovir, Telbivudine, Acyclovir, Entecavir, and Tenofovir. Furthermore, the market is bifurcated based on end use into hospitals pharmacies, pharmacies and drug stores, clinics. Lastly, the global market is partitioned on the basis of geography into North America, Latin America, Europe, Asia-Pacific and Middle East & Africa (MEA).

Report Coverage

Market

Hepatitis Vaccine Market-

Analysis Period

2015 - 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Product, End Use, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

Some of the key players in the hepatitis vaccine market are Bristol-Myers Squibb, Hoffmann- La Roche, GlaxoSmith Kline, plc, Novartis AG, and Merck and Co. among others.

Market Segmentation

Market By Product

  • Lamivudine
  • Hepatitis B vaccine
  • Anti-Viral Drugs
  • Acyclovir
  • Fascornet
  • Adefovir
  • Entecavir
  • Tenofovir
  • Famciclovir
  • Telbivudine

Market By End Use

  • Hospitals pharmacies
  • Pharmacies
  • Drug stores
  • Clinics

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Cancer Biomarkers Market By Type (Protein, Genetic, Others), By Technology (Omics Technology, Immunoassay, Imaging Technology, Cytogenetic Testing), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Leukemia, Thyroid gland Cancer, Kidney Cancer, Bladder Cancer, Others), By Application (Diagnosis, Prognosis, Research, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global cancer biomarkers market size is expected to reach around US$ 29.8 Bn by 2026 and will grow at noteworthy CAGR of around 11.9% over the forecast period 2019 to 2026. Cancer biomarker is a substance that helps to indicate the presence of cancer in the body. This substance may be a molecule secreted by a tumor or specific response of the body to a tumor. Genetic, proteomic

4D Printing in Healthcare Market By Component(Equipment, Software & Services, Programmable Materials), By Technology (PolyJet, FDM, Stereolithography, SLS), By Application (Patient Specific Implant, Medical Research Models, Surgical Guides), By End User (Hospitals, Dental Laboratories, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global 4D printing in healthcare market size is expected to reach around US$ 34.1 Mn by 2026 growing at a CAGR of around 29.6% over the forecast period 2019 to 2026. 4D printing is the latest technology in healthcare that is going to revolutionize the artificial organs and prosthetics industry. 4D printing is a product of collaboration work between MIT’s Lab and Stratasys. 4D printing is evolved 3D p

Healthcare Consulting Services Market By Type of Service (IT Consulting, Digital consulting, Financial Consulting, Operation Consulting, Strategy Consulting, HR & Talent Consulting), By End User (Life Science Companies, Hospitals, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare consulting services market size is expected to reach around US$ 22.8 Bn by 2026 and growing at a CAGR of around 9.8% over the forecast period 2019 to 2026. Healthcare consultancy service providers advice life science companies, government bodies, hospitals, insurance companies, and research institutes about business strategies. Digital consulting, financial consulting, operations consulta

Healthcare Analytics Market By Application (Financial, Clinical, Population Health Analytics, Operational & administrative), By Type (Descriptive, Predictive, Prescriptive, Cognitive), By Deployment Mode (On-premise, On-demand), By End-User (Payer, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare analytics market size is expected to hit around US$ 52.2 Bn by 2026 and will grow at a CAGR of around 23.4% over the forecast period 2019 to 2026. Healthcare analytics are the solutions that involve all the healthcare analysis activities by using data from the key areas of the healthcare: pharmaceutical and R&D data, patient behaviors data, clinical data, and claims & cost data. H

Electronic Health Record Market By Product (Web-based, Client Server-based), By Type (Ambulatory, Acute, Post-Acute), By End Use (Ambulatory Care, Hospitals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global electronic health record market size is expected to reach over US$ 30 Bn by 2026 and is anticipated to grow at a CAGR over 5.5% in terms of revenue during the forecasting period from 2019 to 2026. EMRs refer to both individual patient documents and usually to systems that retain patient documents and serve as data entry interfaces and test ordering, other processes and p

Medical Electronics Market By Application (Imaging, Therapeutics, Patient Monitoring, Homecare/Handheld Products), By End Use (Hospital, Ambulatory Surgical Centers, Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global medical electronics market value is expected to surpass US$ 122 Bn by 2026 and is anticipated to grow at a CAGR of around 6% in terms of revenue during the forecast period from 2019 to 2026. Medical electronics refer to a certain category of electronic instruments and equipment specifically used for medical application such as diagnosis, treatment, study, control of anes

Cart Summary